Significance of early biopsy in pediatric kidney transplantation

Aktuelle Urologie

Volumn 34, Issue 4, 2003, Pages 234-238

  Ishimura, T ^a   Ishida, T ^b   Fujisawa, Masato ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic allograft nephropathy; Fibrosis; Kidney transplantation; Renal function

Indexed keywords

ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE CLEARANCE; EARLY DIAGNOSIS; FEMALE; FIBROSING ALVEOLITIS; FIBROSIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; MALE; ORGAN DONOR; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD;

ADOLESCENT; AGE FACTORS; BIOPSY; CHILD; CHRONIC DISEASE; DATA INTERPRETATION, STATISTICAL; FEMALE; FIBROSIS; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; PROGNOSIS; RISK FACTORS; STAINING AND LABELING; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0041331547     PISSN: 00017868     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41603     Document Type: Conference Paper

References (27)

1. Kahan BD. Cyclosporine. N EnglJ Med 1989; 321: 1725
2. Burke JF, Pirsch JD, Ramos EL, Salomon DR, Srabkein DM, Buren DH van, West JC. Long-term efficacy and safety of cyclosporine in renal transplant recipients. N EnglJ Med 1994; 331: 358
3. Carpenter CB. Long-term failure of renal transplants; adding insult to injury. Kidney Int 1995; 48 (suppl 50): S40
4. Paul LC. Chronic renal transplant loss. Kidney Int 1995; 47: 1491
5. The Canadian Multicenter Transplant Study Group. A randomized trial of cyclosporine in cadavaric renal transplantation. N Engl J Med 1983; 309: 809
6. Bia MJ. Nonimmunologic causes of late renal graft loss. Kidney Int 1995; 47: 1470
7. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Crocker BP, Demetris AJ, Dranchenberg CE, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PP, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Linbrand AS, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen TS, Paradimitriou JC, Randhawa PS, Rayner DC, Roberts I, Rose S, Rush D, Salinas-Madrigal L, Salomon DR, Sund S, Taskinen E, Trpkov K, Yamaguchi Y. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713
8. Kasiske BL, Kalil RS, Lee HS, Rao KY. Histopathologic findings associated with a chronic progressive decline in renal allograft function. Kidney Int 1991; 40: 514
9. Bruijn JA, Hogendorn PCW, Hoedemaeker PJ, Fleuren GJ. The extracellular matrix in pathology. J Lab Clin Med 1988; 111: 140
10. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286
11. Border WA, Rupslahti E. Transforming growth factor-β in disease: The dark side of tissue repair. L Clin Invest 1992; 90: 1
12. Laszlo ZH, Helmut F, Martin S, Bettina B, Judith D, Leslie IG, Murray K, Markus WB. Altered expression of transforming growth factor-βs in chronic renal rejection. Kidney Int 1996; 50: 489
13. Fuad SS, Amie MT, Yuanlin S, Maria IW. Expression of TGF-β and matrix protein is elevated in rats with chronic rejection. Kidney Int 1996; 50: 1904
14. 1 mRNA: A correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 1996; 49: 1297
15. Bulent C, Mysore SAK, Roy DB, Bruce P, Gail H, David AL, Moona A, Carolyn G, Kathy C, Lavjay B, Benjamin CS, Oleh GP. Transforming growth factor-β levels in human allograft chronic fibrosis correlate wirb rate of decline in renal function. Transplantation 1999; 68: 785
16. Roberts AB, Sporn MB. The transforming factor-βs. In: Peptide growth factors and their receptors: Handbook of Experimental Pharmacology, Sporn MB, Roberts AB (eds.). Heidelberg: Springer, 1990; 95: pp 419
17. 3. EMBO J 1987; 6: 1633
18. 1. Kidney Int 1991; 41: 1213
19. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 1990; 86: 453
20. Ignotz RA, Massague J. Transforming growth factor beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337
21. Kehrl JH. Transforming growth factor-13: An important mediator of immunoregulation. Int J Cell Cloning 1991; 9: 438
22. Rush DN, Henry SF, Jeffery JR, Schroeder TJ, Gough J. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994; 57: 208
23. Isoniemi HM, Krogerus L, Willebrand E von, Taskinen E, Ahonen J, Hayry P. Histopathological findings in well-functioning, long-term renal allografts. Kidney Int 1992; 41: 155
24. Rush DN, Jeffery JR, Gough J. sequential protocol biopsies in renal transplant patients. Transplantation 1995; 59: 511
25. Fujisawa M, Ono H, Isotani S, Higuchi A, Iijima K, Yoshiya K, Aarakawa S, Matumoto O, Nakamura H, Kamidono S, Yoshikawa N. Significance of chronic transplant nephropathy on early protocol biopsies for graft outcome in pediatric renal transplantation. Transplant Proc 1999; 31: 1678
26. Thompson NL, Flanders KC, Smith JM, Ellingworth LR, Roberts AB, Sporn MB. Expression of transforming growth faxtor-β, in specific cell and tissues of adult and neonatal mice. J Cell Biol 1989; 108: 661
27. Flanders KC, Roberts AB, Ling N, Fleurdelys BE, Sporn MB. Antibodies to peptide determinants in transforming growth factor-β and their application. Biochemistry 1988; 27: 739